- Record: found
- Abstract: not found
- Article: not found
Clinical outcomes in adults with hemophilia B with and without pre-existing neutralizing antibodies to AAV5: 6 month data from the phase 3 etranacogene dezaparvovec HOPE-B gene therapy trial [abstract]
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.